arrow
N

Nils-Petter Rudqvist

Cornell University
H指数:24
被引数:3,656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
2024-07-311
OAAI
MiNK-215, an IL-15 armored FAP-targeting CAR iNKT cell therapy, effectively treats human organoid models of treatment-refractory MSS colorectal cancer (CRC) liver metastases
2024-03-220
PRE
BMS-986442 ( AGEN1777), a novel TIGIT/CD96 bispecific antibody, demonstrates superior monotherapy and combination activity versus conventional anti-TIGIT antibodies in preclinical models
2024-03-220
PRE
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

ATR介导的CD47和PD-L1上调限制了结直肠癌放疗诱导的免疫启动和远位反应

2022-06-2480
OA
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer
2022-03-1623
OA
CONSTRUCTION OF THE IMMUNE LANDSCAPE OF DURABLE RESPONSE TO CHECKPOINT BLOCKADE THERAPY BY INTEGRATING PUBLICLY AVAILABLE DATASETS
2020-04-150
OAAI
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
2018-11-05697
OAAI